For research use only
| Cat No. | ABC-TC3989 |
| Product Type | Immune Cells |
| Cell Type | T Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Peripheral Blood CD8+ Naive T Killer Cells support T-cell activation and cytotoxicity studies in infectious diseases and cancer models.
Human Peripheral Blood CD8+ Naive T Killer Cells are collected from the peripheral blood of healthy donors and cryopreserved after primary culture. These cells are a subset of cytotoxic T cells that have not encountered their cognate antigen and are characterized by the expression of CD8. They play a central role in initiating cellular immune responses and are critical for defending against intracellular pathogens and cancerous cells. CD8+ naive T cells are important in studies of immune memory formation, T cell differentiation, and immunotherapy development. In vitro, these cells exhibit limited proliferative capacity. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Peripheral Blood CD8+ Naive T Killer Cells, PB CD8+ Naïve CTLs, Naïve Cytotoxic T Cells, CD8+ Naïve Lymphocytes |
| Species | Human |
| Cat.No | ABC-TC3989 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | T Cell |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Immune Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Peripheral Blood CD8+ Naive T Killer Cells offer a valuable model for exploring antigen-specific cytotoxic responses and CD8+ T cell activation. These cells enable studies on clonal expansion, memory differentiation, and effector function development following antigen stimulation. They are especially relevant for research on cancer vaccines, viral infections, and personalized T cell-based immunotherapy.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).